The plant is being further expanded to become a multi-product facility, with three production suites, along with downstream facilities and a total of 110,000 litres of production capacity.
-
Imclone Systems Incorporated's biopharmaceutical manufacturing facility in... -
Graph showing the higher and lower percentages of EGFr in different tumor types. -
The plant is being further expanded to become a multi-product facility, with... -
Facility expansion building under construction. -
Erbitux is a monoclonal antibody that blocks a specific molecular target, the... -
ImClone has a portfolio of targeted biologic treatments designed to address a... -
An excised colorectal tumor.
Twitter